Author: | Iyengar, N. M. |
Title: | Assessing 2024 oncology advances and looking ahead |
Keywords: | antineoplastic agents; drug approval; tyrosine kinase inhibitors; protein kinase inhibitors; antibodies, monoclonal; dna; immunotherapy; artificial intelligence; patient-reported outcomes; trastuzumab; early detection of cancer; information technology; neoplasms -- therapy; neoplasms -- diagnosis; machine learning; oncologic care; liquid biopsy -- methods; glucagon-like peptide-1 receptor agonists |
Journal Title: | Oncology (Norwalk) |
Volume: | 38 |
Issue: | 12 |
ISSN: | 0890-9091 |
Publisher: | C M P Medica LLC * The Oncology Group |
Date Published: | 2024-12-01 |
Start Page: | 457 |
Language: | English |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl plus with full text |
DOI/URL: | |
Notes: | Accession Number: 181425259 -- Entry Date: 20241212 -- Revision Date: 20241212 -- Publication Type: Journal Article; letter -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- Special Interest: Oncologic Care -- NLM UID: 8712059. -- Source: CINAHL Plus with Full Text |